Latest Insider Transactions at Gbs Inc. (GBS)
This section provides a real-time view of insider transactions for Gbs Inc. (GBS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of GBS Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of GBS Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 20
2021
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
100,000
-1.9%
|
$200,000
$2.9 P/Share
|
|
Sep 17
2021
|
Life Science Biosensor Diagnostics Pty LTD |
SELL
Open market or private sale
|
Direct |
45,152
-0.85%
|
$135,456
$3.29 P/Share
|
|
Jun 21
2021
|
Tom Parmakellis Director |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$4,000
$4.44 P/Share
|
|
May 19
2021
|
Spiro Kevin Sakiris Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+38.08%
|
$30,000
$3.07 P/Share
|
|
Mar 02
2021
|
Victoria Gavrilenko Director |
BUY
Open market or private purchase
|
Direct |
36
+50.0%
|
$288
$8.09 P/Share
|
|
Feb 24
2021
|
Christopher Towers Director |
BUY
Open market or private purchase
|
Direct |
800
+50.0%
|
$4,800
$6.84 P/Share
|
|
Jan 18
2021
|
Life Science Biosensor Diagnostics Pty LTD |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
117,647
+1.99%
|
-
|
|
Jan 04
2021
|
Spiro Kevin Sakiris Chief Financial Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
1,479
+19.12%
|
-
|